Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine
申请人:Warner-Lambert Company
公开号:US06084095A1
公开(公告)日:2000-07-04
Novel 4-substituted amino pyrido [3,2-d]pyrimidine inhibitors of epidermal growth factor receptor family of tyrosine kinases are described, as well as pharmaceutical compositions of the same, which are useful in treating proliferative diseases such as cancer, synovial pannus invasion in arthritis, psoriasis, vascular restenosis and angiogenesis and additionally useful in the treatment of pancreatitis and kidney disease as well as a contraceptive agent.
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
申请人:Warner-Lambert Company
公开号:US06521620B1
公开(公告)日:2003-02-18
Described are heterocyclic pyrimidine derivatives and a method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof, a compound of the formula:
where:
at least two of A-E are nitrogen, with the remaining atom(s) carbon;
X=NH or NR7, such that R7=lower alkyl (1-4 carbon atoms), OH, NH2, lower alkoxy (1-4 carbon atoms) or lower monoalkylamino (1-4 carbon atoms);
n=0, 1, 2.
The remaining substituents are described in detail in the specification.